Polypharmacy and the management of the older cancer patient
Open Access
- 1 October 2013
- journal article
- research article
- Published by Elsevier BV in Annals of Oncology
- Vol. 24 (suppl_7), vii36-vii40
- https://doi.org/10.1093/annonc/mdt266
Abstract
Aging is associated with polymorbidity and polypharmacy. In the absence of a consensual definition, polypharmacy has been defined according to the number of drugs that an individual takes or to the presence of the risk of at least one severe drug interaction. In older cancer patients, polypharmacy is at least as common as it is in individuals of the same age without cancer. The management of cancer itself may result in the addition of more medications to counteract the adverse effects of antineoplastic treatment. Polypharmacy may be necessary to control the multiple health conditions of the older person, but it may represent a risk factor for more complications from antineoplastic therapy, and it may affect the outcome of cancer treatment. Polypharmacy is also associated with increased cost. The criteria proposed for the management of polypharmacy include the assessment that all medical conditions are properly treated, the avoidance of drug interactions, and of drugs that may compromise the outcome of antineoplastic treatment and the choice of drugs with the lowest risk of complications in older individuals.Keywords
This publication has 41 references indexed in Scilit:
- Mitochondrial dysfunction in breast cancer cells prevents tumor growthCell Cycle, 2012
- American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older AdultsJournal of the American Geriatrics Society, 2012
- Polypharmacy in elderly patients with cancer: clinical implications and managementThe Lancet Oncology, 2011
- Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter StudyJournal of Clinical Oncology, 2011
- Exposure to Potentially Harmful Drug–Disease Interactions in Older Community‐Dwelling Veterans Based on the Healthcare Effectiveness Data and Information Set Quality Measure: Who Is at Risk?Journal of the American Geriatrics Society, 2011
- Managing Medications in Clinically Complex EldersJAMA, 2010
- Polypharmacy in Older Adults with CancerThe Oncologist, 2010
- Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United StatesJAMA, 2008
- An Electronic Medical Record (EMR)-Based Intervention to Reduce Polypharmacy and Falls in an Ambulatory Rural Elderly PopulationJournal of General Internal Medicine, 2008
- Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated AnemiaJAMA, 2008